MYCOPHENOLATE MOFETIL FOR INJECTION USP DIN 02479974
Status: Dormant
Holder: STERIMAX INC
Available to quote
Health Canada record
| Active ingredient(s) | MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL HYDROCHLORIDE) 500 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L04AA06 MYCOPHENOLIC ACID |
| Original market date | 07-Nov-2018 |
| Current status date | 19-Dec-2024 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sterimax Inc — licence 100925, currently licensed, last inspection rating C (2024-05-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02240347 | CELLCEPT I.V. | HOFFMANN-LA ROCHE LIMITED | Powder For Solution | MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL HYDROCHLORIDE) 500 MG | Marketed |
| 02444836 | MYCOPHENOLATE MOFETIL FOR INJECTION, USP | ACCORD HEALTHCARE INC | Powder For Solution | MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL HYDROCHLORIDE) 500 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 21194 | 2018-08-10 | Abbreviated New Drug Submission (ANDS) |